Bicara Therapeutics BCAX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's quick ratio?
- Bicara Therapeutics (BCAX) reported quick ratio of 13.9× in Q1 2026.
- How has Bicara Therapeutics's quick ratio changed year-over-year?
- Bicara Therapeutics's quick ratio decreased by 43.7% year-over-year, from 24.6× to 13.9×.
- What is the long-term trend for Bicara Therapeutics's quick ratio?
- Over 2 years (2023 to 2025), Bicara Therapeutics's quick ratio has grown at a -2.4% compound annual growth rate (CAGR), from 15.3× to 14.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.